Skip to main content

Table 2 Summary metrics derived from using pure samples from Round 3 for baseline predictions

From: Summarizing performance for genome scale measurement of miRNA: reference samples and metrics

Measurement

 

Data Source

miRNA Detected

Log2 Signals

AUCc

Deviation

Process

Technology

by Round

 

Non-

TrueNeg

TruePos

Lower

Upper

Range

All

Within

Log2 Ratio

Proportion

  

Pure

Mixes

Reps

Selective

1-to-1a

Brain

Placenta

Limitb

Limit

Range

Median

IQR

Sum

A

NGS

3

3

3

928

56

103

104

5.8

20.0

14.3

0.959

0.996

-0.013

0.303

0.375

4

3

5.4

20.2

14.8

0.966

0.988

-0.006

0.311

0.358

5

3

6.3

20.0

13.8

0.899

0.938

-0.059

0.380

0.361

B

NGS

3

3

3

868

56

134

47

7.3

20.2

12.8

0.905

0.953

-0.085

0.387

0.508

4

3

6.3

19.5

13.2

0.866

0.932

-0.092

0.399

0.448

5

3

6.7

19.7

12.9

0.848

0.904

-0.435

0.397

0.565

C

NGS

3

3

3

421

35

29

49

5.3

16.3

11.0

0.944

0.971

0.030

0.266

0.332

4

3

11.1

16.1

5.0

0.831

0.850

0.040

0.626

0.460

5

3

15.7

15.7

0.0

0.848

NDd

-0.124

0.839

0.556

D

NGS

3

3

3

248

16

18

9

8.6

10.6

2.0

0.781

NDd

-0.124

0.627

0.803

4

3

6.1

10.7

4.6

0.956

1.000

-0.178

0.539

0.645

E

Digital Hybridization

3

3

3

693

65

8

24

7.1

13.3

6.1

0.947

1.000

-0.075

0.392

0.460

4

3

7.7

13.7

6.0

0.949

1.000

-0.260

0.495

0.532

5

3

13.2

14.4

1.1

0.925

NDd

-0.257

0.680

0.579

  1. aLiver-selective miRNA or miRNA with approximately equal signals in both brain and placenta
  2. bLower limits for NGS and digital hybridization were calculated with at 95% of values falling within ± 0.585 log2 difference from mean
  3. cROC curves were prepared with P-values using three replicates of Mix1 and Mix2
  4. dNot determined (ND) due to insufficient number of true negative or true positive values